Paediatrica Indonesiana (Sep 2019)

Treatment of Bronchopneumonia with Spiramycine (Rovamycine)

  • Soejono Soejono,
  • Moeljono S. Trastotenojo,
  • Harsoyo N.

DOI
https://doi.org/10.14238/pi16.9-10.1976.396-402
Journal volume & issue
Vol. 16, no. 9-10
pp. 396 – 402

Abstract

Read online

Fifty-seven children with bronchopneumonia, comprising 32 male and 25 female, were admitted to the Department of Child Health, Dr. Kariadi Hospital, Semarang, during the period of May 1972 - May 1973. Varying in ages between 16 days and 7 years, 36 of them were less than one year old. They were treated with spiramycine (Rovamycine) given orally in a dosage of 50 mg/kg body weight daily in three divided doses. The failure was 9 out of 57 cases (15.8%) and in infants 7 out of 36 cases (19.4%). The culture of infants revealed 36.1% staphylococcus and in older children showed 4.8%. All cases of staphylococcus as a single cause which was treated with spiramycine gave good results. No side effects of spiramycine were noted. The study showed that spiramycine has a value in the treatment of childhood bronchopneumonia especially in staphylococcal injections in infants.

Keywords